Common Pitfalls in the Management of Skeletal Metastases

  • Carol D. MorrisEmail author
  • Maria Silvia Spinelli


The surgical management of patients with skeletal metastases presents a unique set of challenges. The potential clinical scenarios and associated complications are endless. This chapter will review some of the common hazards encountered when treating patients with impending and complete pathologic fractures. Specifically, the pitfalls around assumptions about metastatic status and life expectancy will be highlighted. In addition, intraoperative decision-making related to the underlying primary disease and associated complications will be emphasized.


Pathologic fracture Bone cement implantation syndrome Life expectancy Skeletal metastases 


  1. 1.
    Rougraff BT. Evaluation of the patient with carcinoma of unknown origin metastatic to bone. Clin Orthop. 2003;415(Suppl):S105–9. Scholar
  2. 2.
    Adams SC, Potter BK, Mahmood Z, Pitcher JD, Temple HT. Consequences and prevention of inadvertent internal fixation of primary osseous sarcomas. Clin Orthop. 2009;467(2):519–25. Scholar
  3. 3.
    Kebudi R, Ozdemir GN. Secondary neoplasms in children treated for cancer. Curr Pediatr Rev. 2017;13:34–41. PMID: 27848891.CrossRefPubMedGoogle Scholar
  4. 4.
    Moitry M, Velten M, Tretarre B, Bara S, Daubisse-Marliac L, Lapotre-Ledoux B, et al. Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors. Cancer Epidemiol. 2017;47:35–41. Scholar
  5. 5.
    Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian belief network. PLoS One. 2011;6(5):e19956. Scholar
  6. 6.
    Piccioli A, Spinelli MS, Forsberg JA, Wedin R, Healey JH, Ippolito V, et al. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations. BMC Cancer. 2015;15:424. Scholar
  7. 7.
    Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, et al. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23(25):6072–82. Scholar
  8. 8.
    Issack PS, Barker J, Baker M, Kotwal SY, Lane JM. Surgical management of metastatic disease of the proximal part of the femur. J Bone Joint Surg Am. 2014;96(24):2091–8. Scholar
  9. 9.
    Steensma M, Healey JH. Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society members. Clin Orthop. 2013;471(6):2000–6. Scholar
  10. 10.
    Laitinen M, Parry M, Ratasvuori M, Wedin R, Albergo JI, Jeys L, et al. Survival and complications of skeletal reconstructions after surgical treatment of bony metastatic renal cell carcinoma. Eur J Surg Oncol. 2015;41(7):886–92. Scholar
  11. 11.
    Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am. 2007;89(8):1794–801. Scholar
  12. 12.
    Krygier JE, Lewis VO, Cannon CP, Satcher RL, Moon BS, Lin PP. Operative management of metastatic melanoma in bone may require en bloc resection of disease. Clin Orthop. 2014;472(10):3196–203. Scholar
  13. 13.
    Sharma K, Marcus JR. Bevacizumab and wound-healing complications: mechanisms of action, clinical evidence, and management recommendations for the plastic surgeon. Ann Plast Surg. 2013;71(4):434–40. Scholar
  14. 14.
    Marco RA, Sheth DS, Boland PJ, Wunder JS, Siegel JA, Healey JH. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am. 2000;82(5):642–51.CrossRefPubMedGoogle Scholar
  15. 15.
    Tsagozis P, Wedin R, Brosjo O, Bauer H. Reconstruction of metastatic acetabular defects using a modified Harrington procedure. Acta Orthop. 2015;86(6):690–4. Scholar
  16. 16.
    Sim FH. Metastatic bone disease of the pelvis and femur. Instr Course Lect. 1992;41:317–27.PubMedGoogle Scholar
  17. 17.
    Steensma M, Boland PJ, Morris CD, Athanasian E, Healey JH. Endoprosthetic treatment is more durable for pathologic proximal femur fractures. Clin Orthop. 2012;470(3):920–6. Scholar
  18. 18.
    Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18(7):459–69.CrossRefPubMedGoogle Scholar
  19. 19.
    Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys. 1995;31(1):43–9. Scholar
  20. 20.
    Patterson BM, Healey JH, Cornell CN, Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am. 1991;73(2):271–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Xing Z, Moon BS, Satcher RL, Lin PP, Lewis VO. A long femoral stem is not always required in hip arthroplasty for patients with proximal femur metastases. Clin Orthop. 2013;471(5):1622–7. Scholar
  22. 22.
    Moon B, Lin P, Satcher R, Lewis V. Simultaneous nailing of skeletal metastases: is the mortality really that high? Clin Orthop. 2011;469(8):2367–70. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Orthopaedic Oncology, Department of Orthopaedic SurgeryThe Johns Hopkins UniversityBaltimoreUSA
  2. 2.“Fatebene Fratelli” Hospital–Isola TiberinaRomeItaly

Personalised recommendations